Indications 

Cabaser is prescription primarily used in the management or the treatment of Parkinson’s disease and hyperprolactinemia. Parkinson’s disease is a neurological disorder that affects movement and is characterized by symptoms such as resting tremors, slowness of movements (bradykinesia), and rigidity.  

Cabaser is a medication containing the active ingredient cabergoline. Cabergoline belongs to a class of drugs called dopamine agonists, which work by binding to dopamine receptors in the brain. It is known to have potent and long-lasting dopamine D2 receptor agonist properties. It helps to stimulate dopamine receptors, which can improve motor symptoms associated with Parkinson’s disease. 

Use and Dosage 

Cabaser is available in the form of tablet to take it by mouth with or without food as directed by your doctor, usually taken twice a week. Swallow the tablets whole with a full glass of water. Chewing or crushing the tablets may affect the way the medication is absorbed by your body and may increase the risk of side effects.  

The dosage and frequency of Cabaser will depend on the individual’s condition and their response to treatment. However, your doctor will tell you how many tablets to take. The usual starting dose is half to one 1 mg tablet (0.5 mg to 1 mg) a day. Your doctor will gradually increase your dose over several weeks. The recommended maintenance dose is 2 mg to 3 mg a day. Do not take more or less of it or take it more often than prescribed by your doctor. Do not stop taking cabergoline without talking to your doctor. Your doctor will decrease your dose gradually.  

If you miss a dose of Cabaser, take it as soon as you remember. However, if it is close to the time of your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. 

Side Effects 

Common Side Effects

• Breast pain 
• Burning, numbness, or tingling in the arms, hands, legs, or feet 
• Constipation 
• Dizziness 
• Heartburn 
• Nausea 
• Painful menstrual periods 
• Tiredness 
• Vomiting 

Serious Side Effects 

• Abnormal vision 
• Chest pain 
• Cough 
• Decrease in urination 
• Difficulty breathing when lying down 
• Lumps or pain in the stomach area 
• Pain in the back, side, or groin 
• Shortness of breath 
• Swelling of the hands, feet, ankles, or lower legs 

Cautions 

• Allergies: Inform your doctor if you are allergic to cabergoline or any other ergot medications. Discuss any known allergies or sensitivities to medications. 
• Liver Disease: Cabergoline is primarily metabolized in the liver. Patients with severe liver impairment may require a dosage adjustment or close monitoring while taking Cabaser. 
• Cardiac Valve Disorders: There have been rare reports of cardiac valve disorders associated with the use of cabergoline. Inform your doctor if you have a history of heart valve problems. 
• Psychiatric Disorders: Cabaser may cause or exacerbate certain psychiatric disorders, such as hallucinations, confusion, and compulsive behaviors. If you have a history of psychiatric disorders, discuss it with your doctor. 
• Pregnancy and Breastfeeding: Cabergoline should not be used during pregnancy unless specifically instructed by a healthcare professional.  
• Drug Interactions: Cabaser can interact with other medications, including antipsychotic medications, certain antifungals, HIV protease inhibitors, and others. Inform your doctor about all the medications you are taking, including prescription, over-the-counter, and herbal products. 
• Hypotension: Cabaser can cause a drop in blood pressure, leading to symptoms such as dizziness or fainting. If you experience these symptoms, sit or lie down and inform your doctor. 
• Fibrotic Disorders: Cabergoline has been associated with the development of fibrotic disorders, including cardiac fibrosis, pleural effusion, and retroperitoneal fibrosis. If you experience symptoms such as shortness of breath, chest pain, or abdominal pain, seek medical attention. 
• Impulse Control Disorders: Cabergoline has been linked to impulse control disorders, such as compulsive gambling, hypersexuality, and binge eating. If you experience any unusual changes in behavior or urges, notify your doctor. 
• Raynaud’s Phenomenon: Cabergoline may cause constriction of blood vessels, leading to Raynaud’s phenomenon. This condition causes numbness, discoloration, and coldness in the fingers and toes. Inform your doctor if you experience these symptoms. 
• Elderly Patients: Elderly patients may be more susceptible to the side effects of Cabergoline, such as hallucinations and confusion. Close monitoring may be necessary. 
• Driving and Operating Machinery: Cabergoline may cause drowsiness or dizziness, which can impair your ability to drive or operate machinery. Use caution until you know how the medication affects you.